<DOC>
	<DOCNO>NCT01235377</DOCNO>
	<brief_summary>This pilot study method compare common , FDA-approved drug clinic . Instead put single patient one two drug group , investigator assign doctor prescribe drug high blood pressure two group . One group doctor agree prescribe mostly ( `` favor '' ) one drug , chlorthalidone , drug would good choice patient . The group agree prescribe mostly hydrochlorothiazide . For group , try use dose show protective trial . If doctor mostly prescribe drug agree favor , investigator able compare outcome , like heart attack , two group .</brief_summary>
	<brief_title>Tolerance Target Doses Thiazides Actual Practice : A Feasibility Study</brief_title>
	<detailed_description />
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Sodium Chloride Symporter Inhibitors</mesh_term>
	<criteria>VA prescribers thiazides hypertension nonparticipating VA site</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>prescribing pattern</keyword>
	<keyword>thiazide</keyword>
	<keyword>chlorthalidone</keyword>
	<keyword>hydrochlorothiazide</keyword>
	<keyword>target dose</keyword>
	<keyword>cluster randomize trial</keyword>
</DOC>